These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3700681)

  • 1. Controversy I: Patients or healthy volunteers for pharmacokinetic studies?
    Brazzell RK; Colburn WA
    J Clin Pharmacol; 1986 Apr; 26(4):242-7. PubMed ID: 3700681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations in phase I clinical trials.
    Sass HM
    Onkologie; 1990 Apr; 13(2):85-8. PubMed ID: 2197586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some considerations on the design of population pharmacokinetic studies.
    Duffull S; Waterhouse T; Eccleston J
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):441-57. PubMed ID: 16284917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Payments to healthy volunteers--ethical problems.
    Vere DW
    Br J Clin Pharmacol; 1991 Aug; 32(2):141-2. PubMed ID: 1931462
    [No Abstract]   [Full Text] [Related]  

  • 5. Proposal for ethical standards in therapeutic trials.
    Arpaillange P; Dion S; Mathe G
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):887-9. PubMed ID: 3931754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primer on clinical pharmacokinetics.
    Bauer LA
    Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics. A regulatory perspective.
    Sun H; Fadiran EO; Jones CD; Lesko L; Huang SM; Higgins K; Hu C; Machado S; Maldonado S; Williams R; Hossain M; Ette EI
    Clin Pharmacokinet; 1999 Jul; 37(1):41-58. PubMed ID: 10451782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Good clinical practices in therapeutic trials in geriatrics especially in Alzheimer type senile dementia].
    Piette F
    Therapie; 1991; 46(1):83-7. PubMed ID: 2020932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical research with healthy volunteers: an ethical framework.
    Miller FG
    J Investig Med; 2003 Feb; 51 Suppl 1():S2-5. PubMed ID: 12664947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical considerations in the conduct of clinical pharmacokinetic studies.
    Svensson CK
    Clin Pharmacokinet; 1989 Oct; 17(4):217-22. PubMed ID: 2591138
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal.
    Finkelstein MO; Levin B; Robbins H
    Am J Public Health; 1996 May; 86(5):691-5. PubMed ID: 8629721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical problems in interpreting comparative bioavailability trials.
    Westlake WJ
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):342-5. PubMed ID: 1099025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic investigations in elderly patients. Clinical and ethical considerations.
    Abernethy DR; Azarnoff DL
    Clin Pharmacokinet; 1990 Aug; 19(2):89-93. PubMed ID: 2379383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of free drug in phase I: is it useful?
    Barré J; Riant P; Tillement JP
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():141s-150s. PubMed ID: 2093625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conduct of phase I-II clinical trials in children with cancer.
    Pratt CB
    Med Pediatr Oncol; 1991; 19(4):304-9. PubMed ID: 2056975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The randomized controlled clinical trial. Scientific and ethical bases.
    Spodick DH
    Am J Med; 1982 Sep; 73(3):420-5. PubMed ID: 7124768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depo-Provera--ethical issues in its testing and distribution.
    Potts M; Paxman JM
    J Med Ethics; 1984 Mar; 10(1):9-20. PubMed ID: 6231379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.